Your browser doesn't support javascript.
loading
Contribution to global implementation of WHO guideline on control and elimination of human schistosomiasis by learning successful experiences from the national schistosomiasis control program in China / 中国血吸虫病防治杂志
Article 在 Zh | WPRIM | ID: wpr-940942
Responsible library: WPRO
ABSTRACT
Schistosomiasis is a parasitic disease that seriously hinders socioeconomic developments and threatens public health security. To achieve the global elimination of schistosomiasis as a public health problem by 2030, WHO released the guideline on control and elimination of human schistosomiasis on February, 2022, with aims to provide evidence-based recommendations for schistosomiasis morbidity control, elimination of schistosomiasis as a public health problem, and ultimate interruption of schistosomiasis transmission in disease-endemic countries. Following concerted efforts for decades, great achievements have been obtained for schistosomiasis control in China where the disease was historically highly prevalent, and the country is moving towards schistosomiasis elimination. This article reviews the successful experiences from the national schistosmiasis control program in China, and summarizes their contributions to the formulation and implementation of the WHO guideline on control and elimination of human schistosomiasis. With the progress of the "Belt and Road" initiative, the world is looking forward to more China's solutions on schistosomiasis control.
Subject(s)
Key words
全文: 1 索引: WPRIM 主要主题: Schistosomiasis / World Health Organization / China / Public Health / Disease Eradication 研究类型: Guideline / Sysrev_observational_studies 限制: Humans 国家/地区名称主题: Asia 语言: Zh 期刊: Chinese Journal of Schistosomiasis Control 年: 2022 类型: Article
全文: 1 索引: WPRIM 主要主题: Schistosomiasis / World Health Organization / China / Public Health / Disease Eradication 研究类型: Guideline / Sysrev_observational_studies 限制: Humans 国家/地区名称主题: Asia 语言: Zh 期刊: Chinese Journal of Schistosomiasis Control 年: 2022 类型: Article